Jan'05 | Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 26.7% | 29.9% | 28.6% | 25.6% | 30.2% | 26.4% | 24.9% | 17.0% | 17.2% | 19.9% | 22.8% | 22.0% | 23.4% | 2.0% | 25.5% | 25.4% | 24.0% | 30.4% | 23.8% | 18.3% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 20.8%, based on the financial report for Sep 29, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Johnson & Johnson have been 22.9% over the past three years, and 24.8% over the past five years.
As of today, Johnson & Johnson's Return on Equity (ROE) is 20.8%, which is higher than industry median of 18.5%. It indicates that Johnson & Johnson's Return on Equity (ROE) is Good.